Skip to content

N-methyl-d-aspartate receptor hypofunction causes recurrent and transient failures of perceptual inference.

Veith Weilnhammer, Marcus Rothkirch, Deniz Yilmaz, Merve Fritsch, Lena Esther Ptasczynski, Katrin Reichenbach, Lukas Roediger, Philip R. Corlett, Philipp Sterzer

Brain May 13, 2025 DOI: 10.1093/brain/awaf011 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Double-blind, placebo-controlled, cross-over experiment; case-control study Peer reviewed
Population Healthy human participants; individuals with paranoid schizophrenia
Intervention S-ketamine
Topics Ketamine
Keywords Bistable perception Predictive processing Psychosis Schizophrenia Visual perception Psychopharmacology Perception disorders Mental health research Cognitive science
Citations 11
Key findings S-ketamine shifts perception toward the external mode, and individuals with paranoid schizophrenia also spend more time in the external mode, suggesting schizophrenia symptoms may stem from perception dissociating from prior knowledge.

Abstract

Perception integrates external sensory signals with internal predictions that reflect prior knowledge about the world. Previous research suggests that this integration is governed by slow alternations between an external mode, driven by sensory signals, and an internal mode, shaped by prior knowledge. Using a double-blind, placebo-controlled, cross-over experiment in healthy human participants, we investigated the effects of the N-methyl-D-aspartate receptor (NMDAR) antagonist S-ketamine on the balance between external and internal modes. We found that S-ketamine causes a shift of perception towards the external mode. A case-control study revealed that individuals with paranoid schizophrenia, a disorder repeatedly associated with NMDAR hypofunction, spend more time in the external mode. This NMDAR-dependent increase in the external mode suggests that the symptoms of schizophrenia are caused by recurring dissociations of perception from prior knowledge about the world.

Comparable studies

Other randomized controlled trials on ketamine, most cited first.

Study Year Design Participants
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Healthy human subjects recruited from the community 1994 Randomized controlled trial n = 19
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial Patients with treatment-resistant major depression experiencing a major depressive episode 2013 Randomized controlled trial n = 73
Remifentanil-induced Postoperative Hyperalgesia and Its Prevention with Small-dose Ketamine Patients undergoing major abdominal surgery 2005 Randomized controlled trial n = 75
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers Healthy volunteers 2000 Single-blind placebo-controlled study n = 20

Citations in the library

Explore topics